Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 322

Similar articles for PubMed (Select 17671099)

1.

A novel long-acting selective neuropeptide Y2 receptor polyethylene glycol-conjugated peptide agonist reduces food intake and body weight and improves glucose metabolism in rodents.

Ortiz AA, Milardo LF, DeCarr LB, Buckholz TM, Mays MR, Claus TH, Livingston JN, Mahle CD, Lumb KJ.

J Pharmacol Exp Ther. 2007 Nov;323(2):692-700. Epub 2007 Aug 1.

2.

Novel selective neuropeptide Y2 receptor PEGylated peptide agonists reduce food intake and body weight in mice.

Lumb KJ, DeCarr LB, Milardo LF, Mays MR, Buckholz TM, Fisk SE, Pellegrino CM, Ortiz AA, Mahle CD.

J Med Chem. 2007 May 3;50(9):2264-8. Epub 2007 Apr 11.

PMID:
17425299
3.

Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake.

Abbott CR, Small CJ, Kennedy AR, Neary NM, Sajedi A, Ghatei MA, Bloom SR.

Brain Res. 2005 May 10;1043(1-2):139-44.

PMID:
15862527
4.

A long-acting selective neuropeptide Y2 receptor PEGylated peptide agonist reduces food intake in mice.

DeCarr LB, Buckholz TM, Milardo LF, Mays MR, Ortiz A, Lumb KJ.

Bioorg Med Chem Lett. 2007 Apr 1;17(7):1916-9. Epub 2007 Jan 24.

PMID:
17292607
5.

Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice.

Moriya R, Mashiko S, Ishihara A, Takahashi T, Murai T, Ito J, Mitobe Y, Oda Z, Iwaasa H, Takehiro F, Kanatani A.

Peptides. 2009 Jul;30(7):1318-22. doi: 10.1016/j.peptides.2009.04.006. Epub 2009 Apr 23.

PMID:
19394383
6.

Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.

Antal-Zimanyi I, Bruce MA, Leboulluec KL, Iben LG, Mattson GK, McGovern RT, Hogan JB, Leahy CL, Flowers SC, Stanley JA, Ortiz AA, Poindexter GS.

Eur J Pharmacol. 2008 Aug 20;590(1-3):224-32. doi: 10.1016/j.ejphar.2008.06.032. Epub 2008 Jun 12.

PMID:
18573246
7.

PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity.

Vrang N, Madsen AN, Tang-Christensen M, Hansen G, Larsen PJ.

Am J Physiol Regul Integr Comp Physiol. 2006 Aug;291(2):R367-75. Epub 2006 Apr 13.

8.

Selective and brain penetrant neuropeptide y y2 receptor antagonists discovered by whole-cell high-throughput screening.

Brothers SP, Saldanha SA, Spicer TP, Cameron M, Mercer BA, Chase P, McDonald P, Wahlestedt C, Hodder PS.

Mol Pharmacol. 2010 Jan;77(1):46-57. doi: 10.1124/mol.109.058677. Epub 2009 Oct 16.

9.

Intermittent intraperitoneal infusion of peptide YY(3-36) reduces daily food intake and adiposity in obese rats.

Chelikani PK, Haver AC, Reidelberger RD.

Am J Physiol Regul Integr Comp Physiol. 2007 Jul;293(1):R39-46. Epub 2007 Apr 11.

10.
11.

Effects of a novel Y5 antagonist in obese mice: combination with food restriction or sibutramine.

Mashiko S, Ishihara A, Iwaasa H, Moriya R, Kitazawa H, Mitobe Y, Ito J, Gomori A, Matsushita H, Takahashi T, MacNeil DJ, Van der Ploeg LH, Fukami T, Kanatani A.

Obesity (Silver Spring). 2008 Jul;16(7):1510-5. doi: 10.1038/oby.2008.223. Epub 2008 Apr 10.

PMID:
18421274
12.
13.
14.

Identification of selective neuropeptide Y2 peptide agonists.

DeCarr LB, Buckholz TM, Coish PD, Fathi Z, Fisk SE, Mays MR, O'Connor SJ, Lumb KJ.

Bioorg Med Chem Lett. 2007 Jan 15;17(2):538-41. Epub 2006 Oct 7.

PMID:
17055726
15.

Functional consequences of neuropeptide Y Y 2 receptor knockout and Y2 antagonism in mouse and human colonic tissues.

Hyland NP, Sjöberg F, Tough IR, Herzog H, Cox HM.

Br J Pharmacol. 2003 Jun;139(4):863-71.

16.

Effects of exendin-4 alone and with peptide YY(3-36) on food intake and body weight in diet-induced obese rats.

Reidelberger RD, Haver AC, Apenteng BA, Anders KL, Steenson SM.

Obesity (Silver Spring). 2011 Jan;19(1):121-7. doi: 10.1038/oby.2010.136. Epub 2010 Jun 17.

PMID:
20559304
17.

BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist.

Doods H, Gaida W, Wieland HA, Dollinger H, Schnorrenberg G, Esser F, Engel W, Eberlein W, Rudolf K.

Eur J Pharmacol. 1999 Nov 19;384(2-3):R3-5.

PMID:
10611450
18.

Endogenous neuropeptide Y depresses the afferent signaling of gastric acid challenge to the mouse brainstem via neuropeptide Y type Y2 and Y4 receptors.

Wultsch T, Painsipp E, Thoeringer CK, Herzog H, Sperk G, Holzer P.

Neuroscience. 2005;136(4):1097-107. Epub 2005 Oct 10.

19.

Effect of a selective neuropeptide Y Y(2) receptor antagonist, BIIE0246 on neuropeptide Y release.

King PJ, Williams G, Doods H, Widdowson PS.

Eur J Pharmacol. 2000 May 12;396(1):R1-3.

PMID:
10822055
20.

Ventromedial hypothalamic NPY Y2 receptor in the maintenance of body weight in diet-induced obesity in mice.

Huang XF, Yu Y, Li Y, Tim S, Deng C, Wang Q.

Neurochem Res. 2008 Sep;33(9):1881-8. doi: 10.1007/s11064-008-9661-5. Epub 2008 Mar 21.

PMID:
18357520
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk